<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03105180</url>
  </required_header>
  <id_info>
    <org_study_id>B-1703/386-303</org_study_id>
    <nct_id>NCT03105180</nct_id>
  </id_info>
  <brief_title>Irrigating Fluid and Blood Coagulation</brief_title>
  <official_title>The Effect of a Mixture of 2.7% Sorbitol-0.54% Mannitol Solution on Blood Coagulation: In-vitro, Observational Healthy-volunteer Study Using Rotational Thromboelastometry (ROTEM®)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Irrigating fluid absorbed during the endoscopic surgery may alter whole blood coagulation.
      However, little is known about the dose-response relationships of hemodilution. The
      investigators have therefore performed the present study to measure the effect of a mixture
      of 2.7% sorbitol-0.54% mannitol solution on the coagulation pathway according to the
      hemodilution level using a rotational thromboelastometry (ROTEM®) tests.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 10, 2017</start_date>
  <completion_date type="Actual">March 29, 2017</completion_date>
  <primary_completion_date type="Actual">March 29, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>FIBTEM</measure>
    <time_frame>during the rotational thromboelastometry analysis/ an average of 1 hour</time_frame>
    <description>Fibrinolytic pathway values of rotational thromboelastometry analysis/ FIBTEM is s a proper noun which means the status of fibrinolytic coagulation pathway.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>INTEM</measure>
    <time_frame>during the rotational thromboelastometry analysis/ an average of 1 hour</time_frame>
    <description>Intrinsic pathway values of rotational thromboelastometry analysis/ INTEM is a proper noun which means the status of intrinsic coagulation pathway.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>EXTEM</measure>
    <time_frame>during the rotational thromboelastometry analysis/ an average of 1 hour</time_frame>
    <description>Extrinsic pathway values of rotational thromboelastometry analysis/ EXTEM is a proper noun which means the status of extrinsic coagulation pathway.</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Blood Coagulation Disorder</condition>
  <arm_group>
    <arm_group_label>0% dilution</arm_group_label>
    <description>Blood specimen which was diluted with 0% level using a mixture of 2.7% sorbitol-0.54% mannitol solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10% dilution</arm_group_label>
    <description>Blood specimen which was diluted with 10% level using a mixture of 2.7% sorbitol-0.54% mannitol solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20% dilution</arm_group_label>
    <description>Blood specimen which was diluted with 20% level using a mixture of 2.7% sorbitol-0.54% mannitol solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40% dilution</arm_group_label>
    <description>Blood specimen which was diluted with 40% level using a mixture of 2.7% sorbitol-0.54% mannitol solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>A mixture of 2.7% sorbitol-0.54% mannitol solution</intervention_name>
    <description>Venous blood was taken from 12 healthy volunteers and divided into four specimen bottles, which were diluted with different levels (0%, 10%, 20%, and 40%) using a mixture of 2.7% sorbitol-0.54% mannitol solution.</description>
    <arm_group_label>10% dilution</arm_group_label>
    <arm_group_label>20% dilution</arm_group_label>
    <arm_group_label>40% dilution</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers

          -  age: 20 to 65 years

          -  Body weight &gt; 50 kg

          -  Volunteers who provided informed consent

        Exclusion Criteria:

          -  Hematologic disease

          -  Anticoagulant medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyo-Seok Na, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 29, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2017</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Hyo-Seok Na</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Mannitol</mesh_term>
    <mesh_term>Sorbitol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

